Literature DB >> 20299453

Expression of a G protein-coupled receptor (GPCR) leads to attenuation of signaling by other GPCRs: experimental evidence for a spontaneous GPCR constitutive inactive form.

Maria Rosario Tubio1, Natalia Fernandez, Carlos Patricio Fitzsimons, Sabrina Copsel, Sergio Santiago, Carina Shayo, Carlos Davio, Federico Monczor.   

Abstract

The idea of G protein-coupled receptors (GPCRs) coupling to G protein solely in their active form was abolished when it was found that certain ligands induce a G protein-coupled but inactive receptor form. This receptor form interferes with signaling of other receptors by sequestering G protein. However, the spontaneous existence of this receptor species has never been established. The aim of the present work was to evaluate the existence of the spontaneous conformation of the receptor inactively coupled to G protein able to interfere with the response of other GPCRs. According to the law of mass action, receptor overexpression should lead to increased amounts of all spontaneously occurring species. Based on this, we generated Chinese hamster ovary (CHO-K1)-derived cell lines expressing various amounts of the human histamine H2 receptor. In these systems, the signaling of other endogenously and transiently expressed GPCRs was attenuated proportionally to human H2 receptor expression levels. G protein transfection specifically reverted this attenuation, strongly suggesting hijacking of the G protein from a common pool. Similar attenuation effects were observed when the beta(2)- adrenergic receptor was overexpressed, suggesting that this is a more general phenomenon. Moreover, in human mammary MDA-MB-231 cells, a consistent increase in the response of other GPCRs was observed when endogenous expression of beta(2)-adrenergic receptor was knocked down using specific small interfering RNAs. Our findings show that GPCRs may interact with the signaling of other receptors by modulating the availability of the G protein and suggest the existence of GPCR spontaneous coupling to G proteins in an inactive form.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20299453      PMCID: PMC2865266          DOI: 10.1074/jbc.M109.099689

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Histamine H2 receptor desensitization: involvement of a select array of G protein-coupled receptor kinases.

Authors:  C Shayo; N Fernandez; B L Legnazzi; F Monczor; A Mladovan; A Baldi; C Davio
Journal:  Mol Pharmacol       Date:  2001-11       Impact factor: 4.436

Review 2.  Principles: receptor theory in pharmacology.

Authors:  Terry Kenakin
Journal:  Trends Pharmacol Sci       Date:  2004-04       Impact factor: 14.819

3.  Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors.

Authors:  M Shapira; Z Vogel; Y Sarne
Journal:  Cell Mol Neurobiol       Date:  2000-06       Impact factor: 5.046

4.  Retrovirally mediated transfer of a G protein-coupled receptor kinase (GRK) dominant-negative mutant enhances endogenous calcitonin receptor signaling in Chinese hamster ovary cells. GRK inhibition enhances expression of receptors and receptor mRNA.

Authors:  K Horie; P A Insel
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

5.  Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.

Authors:  Alexander V Timoshenko; Guoxiong Xu; Sumontra Chakrabarti; Peeyush K Lala; Chandan Chakraborty
Journal:  Exp Cell Res       Date:  2003-10-01       Impact factor: 3.905

6.  Cardiac-specific overexpression of human beta2 adrenoceptors in mice exposes coupling to both Gs and Gi proteins.

Authors:  A R G Hasseldine; E A Harper; J W Black
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

7.  Tiotidine, a histamine H2 receptor inverse agonist that binds with high affinity to an inactive G-protein-coupled form of the receptor. Experimental support for the cubic ternary complex model.

Authors:  Federico Monczor; Natalia Fernandez; Bibiana Lemos Legnazzi; Maria Eugenia Riveiro; Alberto Baldi; Carina Shayo; Carlos Davio
Journal:  Mol Pharmacol       Date:  2003-08       Impact factor: 4.436

8.  Mepyramine, a histamine H1 receptor inverse agonist, binds preferentially to a G protein-coupled form of the receptor and sequesters G protein.

Authors:  Carlos P Fitzsimons; Federico Monczor; Natalia Fernández; Carina Shayo; Carlos Davio
Journal:  J Biol Chem       Date:  2004-06-10       Impact factor: 5.157

9.  Histamine H1 and H2 receptor gene and protein levels are differentially expressed in the hearts of rodents and humans.

Authors:  Naoyuki Matsuda; Subrina Jesmin; Yoshika Takahashi; Eiichiro Hatta; Masanobu Kobayashi; Kazuto Matsuyama; Nozomi Kawakami; Ichiro Sakuma; Satoshi Gando; Hiyoyuki Fukui; Yuichi Hattori; Roberto Levi
Journal:  J Pharmacol Exp Ther       Date:  2004-01-29       Impact factor: 4.030

10.  Calcitonin targets extracellular signal-regulated kinase signaling pathway in human cancers.

Authors:  Misa Nakamura; Bo Han; Toshihide Nishishita; Yanhua Bai; Kennichi Kakudo
Journal:  J Mol Endocrinol       Date:  2007-12       Impact factor: 5.098

View more
  15 in total

1.  G-protein βγ subunits in vasorelaxing and anti-endothelinergic effects of calcitonin gene-related peptide.

Authors:  M J P M T Meens; N J A Mattheij; P B van Loenen; L J A Spijkers; P Lemkens; J Nelissen; M G Compeer; A E Alewijnse; J G R De Mey
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 2.  Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes.

Authors:  Nicola J Smith; Graeme Milligan
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

3.  Cross-desensitization and cointernalization of H1 and H2 histamine receptors reveal new insights into histamine signal integration.

Authors:  Natalia Alonso; Natalia Fernandez; Cintia Notcovich; Federico Monczor; May Simaan; Alberto Baldi; J Silvio Gutkind; Carlos Davio; Carina Shayo
Journal:  Mol Pharmacol       Date:  2013-03-05       Impact factor: 4.436

4.  Designed cell consortia as fragrance-programmable analog-to-digital converters.

Authors:  Marius Müller; Simon Ausländer; Andrea Spinnler; David Ausländer; Julian Sikorski; Marc Folcher; Martin Fussenegger
Journal:  Nat Chem Biol       Date:  2017-01-16       Impact factor: 15.040

5.  A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer.

Authors:  Lucía Gargiulo; María May; Ezequiel M Rivero; Sabrina Copsel; Caroline Lamb; John Lydon; Carlos Davio; Claudia Lanari; Isabel A Lüthy; Ariana Bruzzone
Journal:  J Mammary Gland Biol Neoplasia       Date:  2017-01-11       Impact factor: 2.673

6.  Resonant waveguide grating biosensor-enabled label-free and fluorescence detection of cell adhesion.

Authors:  Natalya Zaytseva; Jeffery G Lynn; Qi Wu; Deepti J Mudaliar; Haiyan Sun; Patty Q Kuang; Ye Fang
Journal:  Sens Actuators B Chem       Date:  2013-11       Impact factor: 7.460

Review 7.  Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.

Authors:  Brian C Jensen; Timothy D O'Connell; Paul C Simpson
Journal:  J Mol Cell Cardiol       Date:  2010-11-28       Impact factor: 5.000

8.  Differential β₂-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines.

Authors:  Lucía Gargiulo; Sabrina Copsel; Ezequiel M Rivero; Céline Galés; Jean-Michel Sénard; Isabel A Lüthy; Carlos Davio; Ariana Bruzzone
Journal:  Oncotarget       Date:  2014-10-30

9.  Type-3 BRET, an improved competition-based bioluminescence resonance energy transfer assay.

Authors:  James H Felce; Rachel G Knox; Simon J Davis
Journal:  Biophys J       Date:  2014-06-17       Impact factor: 4.033

10.  A synthetic biology-based device prevents liver injury in mice.

Authors:  Peng Bai; Haifeng Ye; Mingqi Xie; Pratik Saxena; Henryk Zulewski; Ghislaine Charpin-El Hamri; Valentin Djonov; Martin Fussenegger
Journal:  J Hepatol       Date:  2016-04-09       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.